调脂降糖片治疗糖尿病血瘀证30例疗效观察

目的 观察调脂降糖片治疗糖尿病血瘀证的治疗效果。方法 将60例患者随机分为两组，调脂降糖片复方组（30例，口服调脂降糖片和肠溶阿司匹林治疗）和西药组（30例，口服肠溶阿司匹林）。结果 复方组临床症状明显改善，与西药组比较差异有显著性（P〈0．05）；治疗后两组患者的血浆内皮素（ET）、一氧化氮（NO）含量以及血黏度指标降低，且复方组作用优于西药组。结论 调脂降糖片具有降低血浆NO、ET含量和血黏度的作用。

Clinical Observation on Effect of Tiaozhi Jiangtang Tablet on Patients with Diabetes of Blood Stasis Syndrome:A Report of 30 Cases

OBJECTIVE: To observe the clinical efficacy of Tiaozhi Jiangtang Tablet (TZJT) on patients suffering from diabetes mellitus with blood stasis syndrome. METHODS: Sixty patients were randomly assigned into 2 groups, the TZJT group (n = 30) treated with TZJT tablet and asprin, the control group (n = 30) treated with asprin alone. RESULTS: The improvement of symptoms was more significant in the TZJT group than that in the control group (P < 0.05). Levels of serum endothelin (ET), nitric oxide (NO) content and blood viscosity were decreased in both groups after treatment, and the effect of TZJT plus asprin was superior to that of asprin alone. CONCLUSION: TZJT combined with asprin is effective in improving the serum content of ET and NO and reducing blood viscosity.